KPHMW — KIORA PHARMACEUTICALS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1372514 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -2,510,195 | -2,417,984 | 21,227,089 | 10,955,359 | 7,292,528 |
| Sep 2025 | 0 | 0 | -794,437 | 26,806 | 29,863,454 | 5,508,899 | 7,452,712 |
| Jun 2025 | 0 | 0 | -2,396,197 | -2,152,459 | 31,945,683 | 1,028,324 | 9,818,207 |
| Mar 2025 | 0 | 0 | -2,330,354 | -2,192,980 | 34,019,862 | 3,771,024 | 10,319,475 |
Annual Trend (SEC EDGAR, last 10y)
Revenues vs Net Income (last 10y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -12,831,073 | -10,835,154 | 24,253,300 | 8,126,764 | 16,126,536 | — |
| Dec 2024 | 16,020,000 | 4,510,288 | 3,594,733 | 36,484,484 | 10,724,708 | 25,759,776 | — |
| Dec 2023 | 173,989 | -12,586,896 | -12,513,896 | 13,711,870 | 7,602,216 | 6,109,654 | — |
| Dec 2022 | 56,891 | -12,309,523 | -13,583,610 | 18,678,259 | 7,270,659 | 11,407,600 | — |
| Dec 2021 | 0 | -16,942,461 | -16,394,919 | 18,057,994 | 8,833,380 | 9,224,614 | — |
| Dec 2020 | 12,059 | -8,212,755 | -8,091,940 | 15,157,559 | 8,158,018 | 6,999,541 | — |
| Dec 2019 | 2,686,000 | 12,481,041 | -7,096,696 | 10,112,514 | 3,490,059 | 6,622,455 | — |
| Dec 2018 | 1,652,520 | -10,844,701 | -10,811,423 | 14,280,617 | 5,344,350 | 8,936,267 | — |
| Dec 2017 | 407,518 | -14,559,239 | -13,217,917 | 14,305,392 | 16,232,314 | -1,926,922 | — |
| Dec 2016 | 669,259 | -13,346,846 | -13,343,437 | 9,730,602 | 10,060,023 | -329,421 | — |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-11,060,158
OpCashFlow TTM
—
Assets (Latest)
$21,227,089
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.04T | $1169.60 | — |
| JNJ | JOHNSON & JOHNSON | $618.09B | $256.48 | — |
| ABBV | AbbVie Inc. | $481.40B | $272.42 | — |
| MRK | Merck & Co., Inc. | $351.28B | $142.38 | — |
| NVS | NOVARTIS AG | $272.01B | $143.11 | — |
Recent Insider Activity
No insider activity indexed for this ticker.